LBT INNOVATIONS LIMITED
ASX
AU Flag
LBT

LBT
LBT INNOVATIONS LIMITED
AU Flag
ASX
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

LBT Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Biotechnology & Medical Research
Employees: ---
LBT Innovations Limited is an Australia-based company, which is engaged in developing clinical and diagnostic technologies. The Company develops technologies for the healthcare and laboratory supply markets. It is involved in research and development activities. The Company's products include MicroStreak and Automated Plate Assessment System (APAS). MicroStreak is an automated culture plate streaking technology that performs the task of streaking (spreading) a clinical sample, such as blood or a biopsy suspension, on a small plate lined with agar gel. APAS is a platform technology for the automation of culture plate screening, evaluation and sorting. MicroStreak automates the inoculation and streaking of the agar plates and APAS streamlines the next stages of the process. The Company has a third product in development called Woundvue, an automation solution to assist in the management and treatment of chronic wounds. It has operations in Australia, Switzerland and the United States.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Help Center Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing TradingView Coins My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out